
Ambit, formerly known as Aventa Biosciences, has hired investment banks Citigroup and Leerink Swann for its $57.5m initial public offering (IPO) after raising more than $165m.
Globes said other Israeli life sciences companies were also planning their US initial public offering, including Kamada, Alcobra and Home Skinovations.
Nokia-backed online advertising services company Rocket Fuel has reportedly selected Credit Suisse and Citigroup to lead its planned initial public offering later this year.
It would have an initial market capitalisation of about $438m, if it floated at $14 per share.
US-based antibody research company KaloBios Pharmaceuticals has raised $70m in its IPO.
Inside Secure has about 15 backers including corporate venturing units from Samsung, Nokia, Qualcomm and Motorola.